Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Packaging debut in Spain

With the March launch of the NaturLínea line of premium milk, Central Lechera Asturiana of Ovieda Asturias, Spain, is the first to commercialize the combishape aseptic packaging concept developed by Sig Combibloc.

Pw 13175 News Natur Linea

"By letting us further enhance product differentiation through carton shape, combishape represents a revolution in the packaging sector," says Pedro Astals, president of CLA’s parent company, CAPSA.

Sig Combibloc has been a recognized leader in aseptic filling of conventional rectangular "drink boxes" for many years. Now the firm claims it has identified more than 40 different basic shapes it can produce with its innovative combishape technology. The key driver behind the whole concept is product differentiation through packaging.

Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report